GB1242863A – 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
– Google Patents
GB1242863A – 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
– Google Patents
2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
Info
Publication number
GB1242863A
GB1242863A
GB2222368A
GB2222368A
GB1242863A
GB 1242863 A
GB1242863 A
GB 1242863A
GB 2222368 A
GB2222368 A
GB 2222368A
GB 2222368 A
GB2222368 A
GB 2222368A
GB 1242863 A
GB1242863 A
GB 1242863A
Authority
GB
United Kingdom
Prior art keywords
signify
alkoxy
alkyl
quinazolines
thiazolo
Prior art date
1968-05-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2222368A
Inventor
Kurt Rubinstein
Erik Falch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia AS
Original Assignee
Pharmacia AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1968-05-10
Filing date
1968-05-10
Publication date
1971-08-18
1968-05-10
Application filed by Pharmacia AS
filed
Critical
Pharmacia AS
1968-05-10
Priority to GB2222368A
priority
Critical
patent/GB1242863A/en
1971-08-18
Publication of GB1242863A
publication
Critical
patent/GB1242863A/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 – C07D507/00
C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 – C07D507/00 in which the condensed system contains two hetero rings
C07D513/04—Ortho-condensed systems
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D277/16—Sulfur atoms
Abstract
1,242,863. Anti-inflammatory &c. medicines. PHARMACIA AS. 9 May, 1969 [10 May, 1968], No. 22223/68. Heading A5B. [Also in Division C2] Pharmaceutical preparations showing, in particular, anti-inflammatory, analgesic, hypothermic and sedative properties, contain as active ingredient compounds I (including salts and hydrates thereof) wherein X is O, S, NH or alkylidene (especially CH 2 ), R 1 and R 2 signify H, alkyl or alkoxy or R 1 and R 3 together signify alkylidene, R 3 and R 4 signify H, OH, alkyl, alkoxy, CO 2 H, alkoxycarbonyl or CONH 2 and R 5 , R 6 , R 7 and R 8 signify H, halogen, CF 3 , OH, alkyl, alkoxy, alkylthio, CO 2 H, alkoxycarbonyl, CONH 2 , NO 2 CN, NH 2 or dialkylamino. Administration may be orally, parenterally or topically and the other actives can be incorporated in the preparations.
GB2222368A
1968-05-10
1968-05-10
2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
Expired
GB1242863A
(en)
Priority Applications (1)
Application Number
Priority Date
Filing Date
Title
GB2222368A
GB1242863A
(en)
1968-05-10
1968-05-10
2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
Applications Claiming Priority (1)
Application Number
Priority Date
Filing Date
Title
GB2222368A
GB1242863A
(en)
1968-05-10
1968-05-10
2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
Publications (1)
Publication Number
Publication Date
GB1242863A
true
GB1242863A
(en)
1971-08-18
Family
ID=10175918
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
GB2222368A
Expired
GB1242863A
(en)
1968-05-10
1968-05-10
2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
Country Status (1)
Country
Link
GB
(1)
GB1242863A
(en)
Cited By (8)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4128648A
(en)
*
1978-03-24
1978-12-05
E. R. Squibb & Sons, Inc.
Substituted pyrano[4,3-d]-thiazolo[3,2-a]pyrimidines
US4128647A
(en)
*
1978-03-24
1978-12-05
E. R. Squibb & Sons, Inc.
Substituted thiazolo [3,2-a]-thiopyrano[4,3-d]pyrimidines
US4332802A
(en)
*
1975-12-19
1982-06-01
Boehringer Ingelheim Kg
11-Oxo-11H-pyrido[2,1-b]quinazoline-2-carboxylic acid and salts thereof, antiallergic compositions containing it and methods of suppressing allergic reactions with it
US4486221A
(en)
*
1981-10-28
1984-12-04
Basf Aktiengesellschaft
Thiazolo[2,3-b]quinazolones and their use for influencing plant growth
US5028705A
(en)
*
1987-09-11
1991-07-02
Basf Aktiengesellschaft
Preparation of pyrazolo[5,1-b]quinazolones
EP0564397A1
(en)
*
1992-03-03
1993-10-06
Sandoz Ltd.
Antiatherosclerotic substituted phenylquinazoline derivatives
DE10046728C1
(en)
*
2000-09-21
2001-09-27
Ibfb Gmbh Privates Inst Fuer B
New mercaptomethyl-substituted tricyclic quinazolinone derivatives, are matrix metalloprotease inhibitors useful for treating cancer, rheumatism, inflammatory reactions or allergies
CN108472267A
(en)
*
2015-12-01
2018-08-31
宝洁公司
Compounds and methods for for inhibiting trimethylamine to generate
1968
1968-05-10
GB
GB2222368A
patent/GB1242863A/en
not_active
Expired
Cited By (8)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4332802A
(en)
*
1975-12-19
1982-06-01
Boehringer Ingelheim Kg
11-Oxo-11H-pyrido[2,1-b]quinazoline-2-carboxylic acid and salts thereof, antiallergic compositions containing it and methods of suppressing allergic reactions with it
US4128648A
(en)
*
1978-03-24
1978-12-05
E. R. Squibb & Sons, Inc.
Substituted pyrano[4,3-d]-thiazolo[3,2-a]pyrimidines
US4128647A
(en)
*
1978-03-24
1978-12-05
E. R. Squibb & Sons, Inc.
Substituted thiazolo [3,2-a]-thiopyrano[4,3-d]pyrimidines
US4486221A
(en)
*
1981-10-28
1984-12-04
Basf Aktiengesellschaft
Thiazolo[2,3-b]quinazolones and their use for influencing plant growth
US5028705A
(en)
*
1987-09-11
1991-07-02
Basf Aktiengesellschaft
Preparation of pyrazolo[5,1-b]quinazolones
EP0564397A1
(en)
*
1992-03-03
1993-10-06
Sandoz Ltd.
Antiatherosclerotic substituted phenylquinazoline derivatives
DE10046728C1
(en)
*
2000-09-21
2001-09-27
Ibfb Gmbh Privates Inst Fuer B
New mercaptomethyl-substituted tricyclic quinazolinone derivatives, are matrix metalloprotease inhibitors useful for treating cancer, rheumatism, inflammatory reactions or allergies
CN108472267A
(en)
*
2015-12-01
2018-08-31
宝洁公司
Compounds and methods for for inhibiting trimethylamine to generate
Similar Documents
Publication
Publication Date
Title
JO1502B1
(en)
1989-01-25
Novel pharmacological compounds
IT1207994B
(en)
1989-06-01
WATER SOLUBLE SALTS OF ANTI-INFLAMMATORY AND ANALGESIC ADAPTITY COMPOUNDS, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS.
MY101177A
(en)
1991-07-31
Improvements in pharmaceutically acceptable salts
IE33269L
(en)
1970-02-20
Pyridobenzodiazepines.
GB1321509A
(en)
1973-06-27
Azepine derivatives
IT1208452B
(en)
1989-06-12
PHARMACEUTICAL PREPARATIONS WITH ANALGESIC EFFECT, AS WELL AS THEIR PRODUCTION AND USE
GB1242863A
(en)
1971-08-18
2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
GB1290818A
(en)
1972-09-27
GB1174051A
(en)
1969-12-10
Aminophenol Derivatives and Analgesic and Antipyretic Compositions
ATE87313T1
(en)
1993-04-15
CEPHEM COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
GB1298603A
(en)
1972-12-06
Quinazolinone derivatives
GB1248430A
(en)
1971-10-06
4-phenyl-quinazolinone derivatives
IE34744L
(en)
1971-05-17
Biphenyl crotonic acids.
MY101821A
(en)
1992-01-31
Quinazolinediones and pyridopyrimidinediones
GB1256723A
(en)
1971-12-15
GB1332697A
(en)
1973-10-03
Benzodiazepine derivatives
GB1190680A
(en)
1970-05-06
Halocinnamoyl Piperidines and Morpholines and Pharmaceutical Compositions Containing Them
GB1359044A
(en)
1974-07-03
Quinoline derivatives
GB1352392A
(en)
1974-05-08
Phenylisopropylamine derivatives
GB1159271A
(en)
1969-07-23
1,5-Disubstituted Barbituric Acid Derivatives and process for the manufacture thereof
GB1092737A
(en)
1967-11-29
2-methoxy-4-[n-glutarylsulfanilamido]quinazoline and process for preparing the same
GB1159272A
(en)
1969-07-23
1,5-Disubstituted Barbituric Acid Derivatives and process for the manufacture thereof
GB1297043A
(en)
1972-11-22
GB1164579A
(en)
1969-09-17
Amino-Dibenz[b,f][[1,4]Oxazepine-11(10H)-Ones
GB1173985A
(en)
1969-12-10
Indole Derivatives
None